Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Lord Lansley and his amendments, just let it pass.....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by InsiderTraderon Jan 12, 2017 11:44pm
136 Views
Post# 25702734

RE:Lord Lansley and his amendments, just let it pass.....

RE:Lord Lansley and his amendments, just let it pass.....
happyretirement wrote: Or since he once worked in the Health Ministry maybe he has found some loopholes
that the Secretary of State may use beyond his authority.....JMO

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.

https://www.publications.parliament.uk/pa/bills/lbill/2016-2017/0081/17081(c).pdf


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities